Schonfeld Strategic Advisors’s Sage Therapeutics SAGE Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-60,000
Closed -$547K 2528
2025
Q2
$547K Buy
60,000
+20,000
+50% +$147K ﹤0.01% 1516
2025
Q1
$318K Buy
+40,000
New +$293K ﹤0.01% 1762
2024
Q4
Sell
-121,316
Closed -$876K 2338
2024
Q3
$876K Buy
121,316
+52,564
+76% +$481K 0.01% 1204
2024
Q2
$747K Buy
+68,752
New +$881K ﹤0.01% 1327
2024
Q1
Sell
-20,992
Closed -$455K 2357
2023
Q4
$455K Sell
20,992
-108,427
-84% -$2.15M ﹤0.01% 1318
2023
Q3
$2.66M Buy
129,419
+108,596
+522% +$3.14M 0.02% 735
2023
Q2
$979K Buy
+20,823
New +$1.04M 0.01% 983
2023
Q1
Sell
-14,872
Closed -$567K 2581
2022
Q4
$567K Buy
14,872
+5,668
+62% +$216K ﹤0.01% 1458
2022
Q3
$360K Buy
+9,204
New +$356K ﹤0.01% 1970
2022
Q2
Sell
-16,680
Closed -$552K 2929
2022
Q1
$552K Buy
+16,680
New +$627K 0.01% 1302
2021
Q2
Sell
-15,333
Closed -$1.15M 2254
2021
Q1
$1.15M Buy
+15,333
New +$1.26M 0.01% 838
2020
Q3
Sell
-20,050
Closed -$834K 1613
2020
Q2
$834K Buy
20,050
+12,381
+161% +$449K 0.02% 662
2020
Q1
$220K Buy
7,669
+4,111
+116% +$238K 0.01% 879
2019
Q4
$257K Sell
3,558
-12,842
-78% -$1.58M 0.01% 1053
2019
Q3
$2.3M Buy
+16,400
New +$2.74M 0.07% 284
2018
Q4
Sell
-8,900
Closed -$1.26M 1217
2018
Q3
$1.26M Buy
+8,900
New +$1.37M 0.06% 382
2017
Q3
Sell
-8,586
Closed -$684K 756
2017
Q2
$684K Buy
+8,586
New +$621K 0.07% 340
2016
Q4
Sell
-30,567
Closed -$1.41M 638
2016
Q3
$1.41M Buy
30,567
+20,567
+206% +$837K 0.24% 116
2016
Q2
$301K Sell
10,000
-1,419
-12% -$47.3K 0.07% 315
2016
Q1
$366K Buy
+11,419
New +$402K 0.15% 183

Other funds holding SAGE